Neurocrine Bio. (NBIX) PT Raised to $195 at UBS
Tweet Send to a Friend
(Updated - October 9, 2025 9:38 AM EDT)
UBS analyst Ashwani Verma raised the price target on Neurocrine Bio ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS analyst Ashwani Verma raised the price target on Neurocrine Bio ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
